Yagmur Okcay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yagmur Okcay has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Ismail Mert Vural
Department of Pharmacology, Gülhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkey
10 shared publications - Emre Avci
Department of Biochemistry, Gulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkey
3 shared publications - Cagil Onal Sis
Pharmaceuticals and Medical Devices Agency of Türkiye, Department of Clinical Trials, Ankara, Turkey
2 shared publications Celil Ilker Askin
Department of Medical Pharmacology, Faculty of Medicine, Gazi University, Ankara, Türkiye
2 shared publications- Kemal Gokhan Ulusoy
Department of Medical Pharmacology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey
2 shared publications - Nurcan Bektas
Anadolu University
2 shared publications
Latest Publications
- Open Access
Investigation of the Effects of Kahweol, Flurbiprofen and Co-Administration of Kahweol and Flurbiprofen on Vas Deferens, Testis and Sperm Against Ischemia-Reperfusion Injury Induced by Testicular Torsion and Detorsion in Rats
Unilateral testicular torsion causes ischemia–reperfusion (I/R) injury, potentially impairing testicular structure and reproductive function. This study investigated the effects of kahweol, flurbiprofen, and their combination on testicular injury and vas deferens contractility following torsion/detorsion in rats. Eighty male Wistar albino rats were divided into five groups: sham, torsion/detorsion, kahweol, flurbiprofen, and combination. Following 2 h of unilateral testicular torsion, treatments were administered immediately after detorsion and continued for six days. Histopathological, biochemical, spermatological, and isolated organ bath analyses were performed on day 7. Torsion/detorsion caused severe ipsilateral histopathological damage, increased caspase-3 immunoreactivity, and impaired vas deferens contractility. All treatments reduced caspase-3 immunoreactivity but failed to significantly improve histopathological damage. Changes in inflammatory mediators and oxidative stress markers were variable, without consistent evidence of antioxidant protection. Flurbiprofen and combination treatment partially improved noradrenaline-induced contractions, while combined treatment enhanced electrical field stimulation-induced responses in the prostatic vas deferens. Spermatological findings were limited by sample availability and variability. These findings suggest that flurbiprofen, alone or combined with kahweol, may partially improve selected functional outcomes following testicular I/R injury, although substantial structural damage persists.
Open AccessInvestigation of the Effects of Kahweol, Flurbiprofen and Co-Administration of Kahweol and Flurbiprofen on Vas Deferens, Testis and Sperm Against Ischemia-Reperfusion Injury Induced by Testicular Torsion and Detorsion in Rats
Unilateral testicular torsion causes ischemia–reperfusion (I/R) injury, potentially impairing testicular structure and reproductive function. This study investigated the effects of kahweol, flurbiprofen, and their combination on testicular injury and vas deferens contractility following torsion/detorsion in rats. Eighty male Wistar albino rats were divided into five groups: sham, torsion/detorsion, kahweol, flurbiprofen, and combination. Following 2 h of unilateral testicular torsion, treatments were administered immediately after detorsion and continued for six days. Histopathological, biochemical, spermatological, and isolated organ bath analyses were performed on day 7. Torsion/detorsion caused severe ipsilateral histopathological damage, increased caspase-3 immunoreactivity, and impaired vas deferens contractility. All treatments reduced caspase-3 immunoreactivity but failed to significantly improve histopathological damage. Changes in inflammatory mediators and oxidative stress markers were variable, without consistent evidence of antioxidant protection. Flurbiprofen and combination treatment partially improved noradrenaline-induced contractions, while combined treatment enhanced electrical field stimulation-induced responses in the prostatic vas deferens. Spermatological findings were limited by sample availability and variability. These findings suggest that flurbiprofen, alone or combined with kahweol, may partially improve selected functional outcomes following testicular I/R injury, although substantial structural damage persists.
- 16 October 2026
- Published by Akademiai Kiado Zrt. in Imaging
- Vol. 113 (3) , 431-442
Effects of Propranolol, Metoprolol, and Nebivolol on isolated rat atrial preparations and thoracic aorta: Involvement of nitric oxide in nebivolol-induced negative chronotropic and inotropic responses
Background: Propranolol (a non-selective β -blocker), metoprolol (a β1-selective blocker), and nebivolol (a β1-selective blocker with nitric oxide (NO)–releasing properties) are widely used in the treatment of various cardiovascular diseases. Based on their distinct pharmacological profiles at β -adrenergic receptors, we aimed to comparatively evaluate their effects on chronotropic, inotropic, and vascular responses in isolated rat atria and thoracic aorta preparations. Methods: In this study, isolated right, left atria and thoracic aorta preparations were used and mounted in organ bath systems. The right atrium was used to assess spontaneous beating rate (chronotropic responses), whereas the left atrium was used to evaluate contractile force (inotropic responses). Cumulative concentration–response curves were obtained by administering increasing concentrations (10 −9 –10 −5 M) of propranolol, metoprolol, and nebivolol in noradrenaline (NA)-stimulated atrial preparations. To determine the contribution of NO, nebivolol-induced negative chronotropic and inotropic responses were also examined in the presence of the NO synthase inhibitor L-NAME (10 −5 M). In endothelium-intact thoracic aorta rings, NA-induced contractile responses were also evaluated in the presence of each β -blocker with different concentrations (10 −7 , 10 −6 , 10 −5 M). Results: Propranolol, metoprolol, and nebivolol produced negative chronotropic and inotropic effects in a concentration-dependent manner in isolated right and left atrial preparations. The negative chronotropic and inotropic effects of nebivolol were significantly attenuated in the presence of L-NAME ( P < 0.05). NA induced a concentration-dependent increase in contractile responses in endothelium-intact aortic rings. Propranolol, metoprolol, and nebivolol caused rightward shifts of the NA concentration–response curves and Schild plot analysis revealed pA 2 values of 6.64 ± 0.47, 6.47 ± 0.46, and 6.95 ± 0.35, respectively. Conclusion: These findings demonstrate that propranolol, metoprolol, and nebivolol show differential pharmacological profiles affecting atrial and vascular responses under NA stimulation in isolated rat atrial and aorta preparations. Notably, NO appears to be a key mediator of nebivolol's cardiac effects, reflected in its pronounced negative chronotropic and inotropic responses in isolated atrial tissues.
- 16 October 2026
- Published by Akademiai Kiado Zrt. in Imaging
- Vol. 113 (3) , 431-442
Effects of Propranolol, Metoprolol, and Nebivolol on isolated rat atrial preparations and thoracic aorta: Involvement of nitric oxide in nebivolol-induced negative chronotropic and inotropic responses
Background: Propranolol (a non-selective β -blocker), metoprolol (a β1-selective blocker), and nebivolol (a β1-selective blocker with nitric oxide (NO)–releasing properties) are widely used in the treatment of various cardiovascular diseases. Based on their distinct pharmacological profiles at β -adrenergic receptors, we aimed to comparatively evaluate their effects on chronotropic, inotropic, and vascular responses in isolated rat atria and thoracic aorta preparations. Methods: In this study, isolated right, left atria and thoracic aorta preparations were used and mounted in organ bath systems. The right atrium was used to assess spontaneous beating rate (chronotropic responses), whereas the left atrium was used to evaluate contractile force (inotropic responses). Cumulative concentration–response curves were obtained by administering increasing concentrations (10 −9 –10 −5 M) of propranolol, metoprolol, and nebivolol in noradrenaline (NA)-stimulated atrial preparations. To determine the contribution of NO, nebivolol-induced negative chronotropic and inotropic responses were also examined in the presence of the NO synthase inhibitor L-NAME (10 −5 M). In endothelium-intact thoracic aorta rings, NA-induced contractile responses were also evaluated in the presence of each β -blocker with different concentrations (10 −7 , 10 −6 , 10 −5 M). Results: Propranolol, metoprolol, and nebivolol produced negative chronotropic and inotropic effects in a concentration-dependent manner in isolated right and left atrial preparations. The negative chronotropic and inotropic effects of nebivolol were significantly attenuated in the presence of L-NAME ( P < 0.05). NA induced a concentration-dependent increase in contractile responses in endothelium-intact aortic rings. Propranolol, metoprolol, and nebivolol caused rightward shifts of the NA concentration–response curves and Schild plot analysis revealed pA 2 values of 6.64 ± 0.47, 6.47 ± 0.46, and 6.95 ± 0.35, respectively. Conclusion: These findings demonstrate that propranolol, metoprolol, and nebivolol show differential pharmacological profiles affecting atrial and vascular responses under NA stimulation in isolated rat atrial and aorta preparations. Notably, NO appears to be a key mediator of nebivolol's cardiac effects, reflected in its pronounced negative chronotropic and inotropic responses in isolated atrial tissues.
- Open Access
Engineering Red Blood Cell Membrane-Coated PLGA Nanoparticles for Kahweol Delivery: Formulation Development and Pharmacokinetic Assessment
Kahweol is an active diterpene with anti-inflammatory, antioxidant, and anticancer properties; however, its use may be limited by unfavorable pharmacokinetic characteristics. This study aimed to develop kahweol-loaded poly(lactic-co-glycolic acid) (PLGA) and red blood cell membrane-coated PLGA (RBC-PLGA) nanoparticles and evaluate their in vitro release behavior and in vivo pharmacokinetic profiles. Kahweol-loaded PLGA nanoparticles were prepared using the emulsification-solvent evaporation method and subsequently coated with rabbit erythrocyte membranes, a type of blood cell membrane, to obtain RBC-PLGA nanoparticles. Particle size, zeta potential, morphology, and encapsulation efficiency were characterized. In vitro release studies were performed using the dialysis bag method. Pharmacokinetic profiles of free kahweol, kahweol-loaded PLGA, and kahweol-loaded RBC-PLGA nanoparticles were evaluated in rabbits following intravenous administration (0.5 mg/kg), and plasma kahweol concentrations were analyzed by LC-MS/MS. PLGA and RBC-PLGA nanoparticles showed high encapsulation efficiency (>90%) and sustained biphasic release compared with the rapid burst release of free kahweol. Pharmacokinetic analysis demonstrated that PLGA and RBC-PLGA nanoparticles reduced peak plasma concentrations and prolonged systemic exposure. Among the nanoparticles, RBC-PLGA exhibited the most prolonged pharmacokinetic profile, with delayed time to maximum plasma concentration (Tmax), extended half-life, and increased overall exposure. The nanoparticles improved the pharmacokinetic profile of kahweol by enabling sustained release and prolonged systemic exposure, supporting their potential as delivery platforms for future applications.
Open AccessEngineering Red Blood Cell Membrane-Coated PLGA Nanoparticles for Kahweol Delivery: Formulation Development and Pharmacokinetic Assessment
Kahweol is an active diterpene with anti-inflammatory, antioxidant, and anticancer properties; however, its use may be limited by unfavorable pharmacokinetic characteristics. This study aimed to develop kahweol-loaded poly(lactic-co-glycolic acid) (PLGA) and red blood cell membrane-coated PLGA (RBC-PLGA) nanoparticles and evaluate their in vitro release behavior and in vivo pharmacokinetic profiles. Kahweol-loaded PLGA nanoparticles were prepared using the emulsification-solvent evaporation method and subsequently coated with rabbit erythrocyte membranes, a type of blood cell membrane, to obtain RBC-PLGA nanoparticles. Particle size, zeta potential, morphology, and encapsulation efficiency were characterized. In vitro release studies were performed using the dialysis bag method. Pharmacokinetic profiles of free kahweol, kahweol-loaded PLGA, and kahweol-loaded RBC-PLGA nanoparticles were evaluated in rabbits following intravenous administration (0.5 mg/kg), and plasma kahweol concentrations were analyzed by LC-MS/MS. PLGA and RBC-PLGA nanoparticles showed high encapsulation efficiency (>90%) and sustained biphasic release compared with the rapid burst release of free kahweol. Pharmacokinetic analysis demonstrated that PLGA and RBC-PLGA nanoparticles reduced peak plasma concentrations and prolonged systemic exposure. Among the nanoparticles, RBC-PLGA exhibited the most prolonged pharmacokinetic profile, with delayed time to maximum plasma concentration (Tmax), extended half-life, and increased overall exposure. The nanoparticles improved the pharmacokinetic profile of kahweol by enabling sustained release and prolonged systemic exposure, supporting their potential as delivery platforms for future applications.
- 10 September 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1034
Diminazene aceturate-induced relaxation in isolated rat thoracic aorta: Contribution of cannabinoid and vanilloid signaling
- 10 September 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1034
Diminazene aceturate-induced relaxation in isolated rat thoracic aorta: Contribution of cannabinoid and vanilloid signaling
- 31 August 2026
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 51 (2) , 517-530
Effects of Diminazene Aceturate on Isolated Rat Bladder Tissue: Role of Nitric Oxide and Cyclooxygenase Pathways
Diminazene aceturate (DIZE) is a compound reported to activate ACE2. This study aimed to investigate the effects of DIZE on isolated rat bladder tissue, and to evaluate the potential involvement of nitric oxide (NO) and cyclooxygenase (COX) pathways. Isolated rat bladder strips were mounted in organ baths. The effects of cumulative DIZE administration were examined on basal tone and on carbachol-precontracted tissues. Neurogenic contractions were assessed using electrical field stimulation (EFS) after incubation with vehicle or DIZE, and under DIZE conditions in the presence of L-NAME (NOS inhibitor) or flurbiprofen (COX inhibitor). ACE2 and Ang (1–7) levels were quantified in bladder homogenates by ELISA. In carbachol-precontracted strips, DIZE induced a concentration-dependent relaxation. This relaxant response was not significantly modified by L-NAME or flurbiprofen. In EFS experiments, DIZE attenuated frequency-dependent neurogenic contractions, with more pronounced inhibition at higher frequencies. Under DIZE incubation, L-NAME partially reversed the suppression of high-frequency EFS responses (particularly in the integrated/area measure), whereas flurbiprofen did not produce a comparable reversal. In ELISA analyses, ACE2 and Ang (1–7) tissue levels were not significantly altered by DIZE under the conditions tested. DIZE modulates rat bladder contractility by relaxing muscarinic tone and dampening neurogenic contractions. The direct relaxant effect appears largely independent of NOS and COX pathways, whereas NO may contribute to DIZE’s modulation of high-frequency neurogenic responses. Lack of major ELISA changes suggests stable steady-state ACE2/Ang (1–7) levels in healthy bladder, warranting further in vivo and disease-model studies.
- 31 August 2026
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 51 (2) , 517-530
Effects of Diminazene Aceturate on Isolated Rat Bladder Tissue: Role of Nitric Oxide and Cyclooxygenase Pathways
Diminazene aceturate (DIZE) is a compound reported to activate ACE2. This study aimed to investigate the effects of DIZE on isolated rat bladder tissue, and to evaluate the potential involvement of nitric oxide (NO) and cyclooxygenase (COX) pathways. Isolated rat bladder strips were mounted in organ baths. The effects of cumulative DIZE administration were examined on basal tone and on carbachol-precontracted tissues. Neurogenic contractions were assessed using electrical field stimulation (EFS) after incubation with vehicle or DIZE, and under DIZE conditions in the presence of L-NAME (NOS inhibitor) or flurbiprofen (COX inhibitor). ACE2 and Ang (1–7) levels were quantified in bladder homogenates by ELISA. In carbachol-precontracted strips, DIZE induced a concentration-dependent relaxation. This relaxant response was not significantly modified by L-NAME or flurbiprofen. In EFS experiments, DIZE attenuated frequency-dependent neurogenic contractions, with more pronounced inhibition at higher frequencies. Under DIZE incubation, L-NAME partially reversed the suppression of high-frequency EFS responses (particularly in the integrated/area measure), whereas flurbiprofen did not produce a comparable reversal. In ELISA analyses, ACE2 and Ang (1–7) tissue levels were not significantly altered by DIZE under the conditions tested. DIZE modulates rat bladder contractility by relaxing muscarinic tone and dampening neurogenic contractions. The direct relaxant effect appears largely independent of NOS and COX pathways, whereas NO may contribute to DIZE’s modulation of high-frequency neurogenic responses. Lack of major ELISA changes suggests stable steady-state ACE2/Ang (1–7) levels in healthy bladder, warranting further in vivo and disease-model studies.
- 13 March 2025
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 81 (5) , 625-645
A narrative review of the placebo effect: historical roots, current applications, and emerging insights
Placebo is a term to define physiologically inactive compounds used in treatment that causes physical and emotional changes. The placebo effect, driven by
- 13 March 2025
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 81 (5) , 625-645
A narrative review of the placebo effect: historical roots, current applications, and emerging insights
Placebo is a term to define physiologically inactive compounds used in treatment that causes physical and emotional changes. The placebo effect, driven by
- 3 December 2024
- Published by Elsevier in Neuroscience Letters
- Vol. 845, 138075
Exploring the antinociceptive effect of taraxasterol in mice: Possible mechanisms
- 3 December 2024
- Published by Elsevier in Neuroscience Letters
- Vol. 845, 138075
Exploring the antinociceptive effect of taraxasterol in mice: Possible mechanisms
- 3 July 2024
- Published by Elsevier in Ageing Research Reviews
- Vol. 99, 102401
Dynamic endocannabinoid-mediated neuromodulation of retinal circadian circuitry
- 3 July 2024
- Published by Elsevier in Ageing Research Reviews
- Vol. 99, 102401
Dynamic endocannabinoid-mediated neuromodulation of retinal circadian circuitry
- 7 May 2024
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 38 (5) , 967-977
The relaxation effect of endocannabinoid anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms
Background: The endocannabinoid system plays important roles in various systems, including the genitourinary system; however, its mechanism of action is not fully understood.Objectives: This study aimed to investigate the direct relaxant effects of anandamide and its possible mechanisms in isolated rat bladder and vas deferens tissues.Methods: Twenty‐one adult male Wistar albino rats were used. Bladder and vas deferens (prostatic and epididymal portions) tissues were mounted in 10 mL of organ baths. Relaxation responses to anandamide were recorded at 3 and 10 μM concentrations. After the rest period, the procedures were repeated in the presence of cannabinoid (CB) and vanilloid receptor antagonists, various potassium channel blockers, cyclo‐oxygenase, and nitric oxide synthase inhibitors. In different tissues to investigate the Ca2+‐channel antagonistic effect of anandamide, concentration–response curves to CaCl2 were obtained in the absence and presence of anandamide.Results: Anandamide caused a significant relaxation response in the bladder and epididymal vas deferens tissues, but not in the prostatic portion. The effect of anandamide was antagonized in the presence of the CB1 antagonist AM251 or the non‐selective potassium channel blocker tetraethylammonium in bladder tissue. In the epididymal vas deferens, anandamide significantly inhibited the calcium contraction responses, especially at high concentrations. The CB2 antagonist AM630 reversed this inhibition.Conclusions: The results show that anandamide has a direct relaxant effect on the isolated rat bladder and epididymal vas deferens. Anandamide triggers different mechanisms in different types of tissues, and further studies are needed to elucidate the mechanism of action of anandamide.
- 7 May 2024
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 38 (5) , 967-977
The relaxation effect of endocannabinoid anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms
Background: The endocannabinoid system plays important roles in various systems, including the genitourinary system; however, its mechanism of action is not fully understood.Objectives: This study aimed to investigate the direct relaxant effects of anandamide and its possible mechanisms in isolated rat bladder and vas deferens tissues.Methods: Twenty‐one adult male Wistar albino rats were used. Bladder and vas deferens (prostatic and epididymal portions) tissues were mounted in 10 mL of organ baths. Relaxation responses to anandamide were recorded at 3 and 10 μM concentrations. After the rest period, the procedures were repeated in the presence of cannabinoid (CB) and vanilloid receptor antagonists, various potassium channel blockers, cyclo‐oxygenase, and nitric oxide synthase inhibitors. In different tissues to investigate the Ca2+‐channel antagonistic effect of anandamide, concentration–response curves to CaCl2 were obtained in the absence and presence of anandamide.Results: Anandamide caused a significant relaxation response in the bladder and epididymal vas deferens tissues, but not in the prostatic portion. The effect of anandamide was antagonized in the presence of the CB1 antagonist AM251 or the non‐selective potassium channel blocker tetraethylammonium in bladder tissue. In the epididymal vas deferens, anandamide significantly inhibited the calcium contraction responses, especially at high concentrations. The CB2 antagonist AM630 reversed this inhibition.Conclusions: The results show that anandamide has a direct relaxant effect on the isolated rat bladder and epididymal vas deferens. Anandamide triggers different mechanisms in different types of tissues, and further studies are needed to elucidate the mechanism of action of anandamide.